Anti-Human CD37 Recombinant Antibody(Otlertuzumab)

Product Information

Catalog Number	YR1329
Product Name	Anti-Human CD37 Recombinant Antibody(Otlertuzumab)
Molecular Name	Otlertuzumab
Alias	Anti-CD37 Recombinant Antibody, Research Grade Otlertuzumab
CAS Number	1372645-37-8
Target	CD37[Homo sapiens]
Isotype	VH-V Kappa-CH2-CH3
Clonity	Monoclonal
Source	CHO Cells
Size	1mg, 5mg
Concentration	1mg/ml
Purity	>95% as determined by SDS-PAGE
Applications	ELISA, IP, FCM, FuncS, Neut, IF, ICC
Buffer	PBS, pH7.5
Background	Otlertuzumab (TRU- 016) is a humanized monoclonal antibody that targets CD37 designed for the treatment of cancer. This drug was developed by Emergent BioSolutions and has been in clinical trails for lymphoma and Chronic Lymphocytic Leukemia (CLL).
Storage	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note	This product is for research use only.

Cat#	Product Name	Species	Host	Applications	Size	Price